spok.com - SPOK Company Value to Revenue Ratio

Public company logo of Spok (SPOK)

Spok Holdings, Inc. (SPOK) is implementing an eco-friendly approach by replacing paper workflows in clinics with digital services. This complements its status as a critical communications leader and the migration to the Spok Go platform. The enterprise value-to-revenue ratio clearly confirms the real-time valuation, where 1466.62 serves as the current metric level. Stable cash flow from paging ensures margin resilience and controlled cost growth.

SPOK spok.com: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/20/2026

SPOK (USA Mobility): analytical breakdowns and indicator data

- money and cash flow information:
Fundamental valuation:Spok Holdings, Inc. SPOK
Signature product of Spok Corp

This metric combines market capitalization and net debt, comparing the total enterprise value to sales volume. This ratio allows for an assessment of the asset's real price by excluding the influence of financing structure on fundamental value. For Spok Holdings, Inc. (SPOK), stable demand for critical communication systems in healthcare makes this indicator a reliable gauge of operational resilience. Analyzing the company's valuation based on revenue excluding debt helps identify if the asset is overbought. The dynamics of this curve protect the investor from purchasing depreciating securities.

Competitor analysis for Spok Holdings, Inc.

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|absci.com - Enterprise Value-to-Revenue Ratio|SY - Enterprise Value-to-Revenue Ratio|Business Value to Revenue NRC (National Research)|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)